1. An update on European Paediatric Formulation Initiative (EuPFi)
Dr Catherine TULEU
Reader, Department of Pharmaceutics
&
Director, Centre for Paediatric Pharmacy Research
Age Related Medicines Focus Group meeting - Monday 30th September

2. CPPR Centre for Paediatric Pharmacy Research
Parents
Carers
Formulation Medicines Child Safety
Prescribers
Since 2002 (Prof IK Wong)
PK/PD PG
Dr Joseph Standing
(ICH/GOSH)
Dr Yogini Jani (UCLH)
Dr Tuleu (director)
MCRN P&P CSG (2005-)
FWG PDCO external expert (2007-)
PEAG MHRA (2010-)
EuPFi Chair (2007-)
FP7 Network of excellence
( )
RA, PhD, Mres, MSc, Visiting & Erasmus, Mpharm students
Drug utilisation
Dr Macey Murray
Compliance Adherence Concordance
Pharmaco-epidemiology

3. European Paediatric Formulation Initiative
objectives
Identify the issues and challenges associated with development of paediatric formulation and consider ways towards better medications and clinically relevant dosage forms for children
Promote early pharmaceutical consideration for development of paediatric medicines.
Identify potential information, knowledge, know-how gaps in the paediatric formulation development.
Improve the availability of information of paediatric formulations.
Raising awareness (publications, conferences etc.)
Linking and networking
Quick fact:
Non profit organisation
Core management group
Members from industry, academia, hospital and regulatory agencies dedicated to fulfilling its mission.
Established in London in 2007.
Membership open to anyone interested in paediatric formulation development.
5 Workstreams
Annual Conferences

4. EuPFI members SPONSORS OBSERVER Mission
To promote and facilitate preparation of better & safe medicines for children through
Sharing expertise and interactive discussion between industry, academia, clinical and regulatory professionals.
Information dissemination
USA
-Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative
I-Q consortium

5. Accepted for publication
Accomplishments
WS 1
WS 2
WS 3
WS4
WS5
Administration Devices
Modification of Dosage Forms Required for Children (MDFRC)
Taste Masking and Taste Testing
Age Appropriateness of Formulations
Pharmaceutical Excipients
Accepted for publication
Submitted to ADDR

6. Formulating better medicines for children
1st conference with APS
2009, LONDON
100 participants
Formulating better medicines for children
6th conference
17th to 18th September 2014
Athens, Greece
participants